Target Price | $49.20 |
Price | $24.05 |
Potential |
104.57%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target Beam Therapeutics Inc 2025 .
The average Beam Therapeutics Inc target price is $49.20.
This is
104.57%
register free of charge
$80.00
232.64%
register free of charge
$23.00
4.37%
register free of charge
|
|
A rating was issued by 18 analysts: 10 Analysts recommend Beam Therapeutics Inc to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Beam Therapeutics Inc stock has an average upside potential 2025 of
104.57%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 377.71 | 50.72 |
520.01% | 86.57% | |
EBITDA Margin | -41.43% | -796.77% |
92.01% | 1,823.36% | |
Net Margin | -37.60% | -767.98% |
93.28% | 1,942.73% |
17 Analysts have issued a sales forecast Beam Therapeutics Inc 2024 . The average Beam Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Beam Therapeutics Inc EBITDA forecast 2024. The average Beam Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 Beam Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Beam Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.72 | -4.72 |
58.35% | 174.42% | |
P/E | negative | |
EV/Sales | 24.21 |
17 Analysts have issued a Beam Therapeutics Inc forecast for earnings per share. The average Beam Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Beam Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Beam Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.